{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-001611","form_type":"8-K","ticker":"TGNT","cik":"0000846377","company_name":"Totaligent, Inc.","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.816800+00:00","generated_at":"2026-05-15T08:45:19.303434+00:00","sec_items":["1.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"medium","headline":"Totaligent extends GloMed joint venture LOI deadline to April 22, 2026","bullets":["Extension Amendment moves target closing date from March 22 to April 22, 2026.","Binding exclusivity period extended through April 22, 2026.","Delay attributed to ongoing due diligence and negotiations for definitive agreements.","All other terms of the original LOI remain unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-001611","json":"https://secwatch.observer/filing/0001477932-26-001611.json","markdown":"https://secwatch.observer/filing/0001477932-26-001611.md","text":"https://secwatch.observer/filing/0001477932-26-001611.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001611/0001477932-26-001611-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001611/totaligent_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:45:19.303434+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9f866a0397a3317a2f0003c705868a332583d6ac","claim":"Totaligent, Inc. amended Extension Amendment with GloMed Solutions Limited Liability Company (effective 2026-03-22).","evidence_excerpt":"On March 22, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 22, 2026 (the “LOI”) with GloMed Solutions Limited Liability Company (“GloMed”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001611/0001477932-26-001611-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"GloMed Solutions Limited Liability Company"},{"label":"Effective","value":"2026-03-22"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}